Ventavis

Ventavis is a brand name of iloprost, approved by the FDA in the following formulation(s):

VENTAVIS (iloprost - solution; inhalation)

• 
  Manufacturer: ACTELION PHARMS LTD
  
  Approval date: December 8, 2005
  
  Strength(s): 10MCG/ML (10MCG/ML) ^[RLD]


• 
  Manufacturer: ACTELION PHARMS LTD
  
  Approval date: August 7, 2009
  
  Strength(s): 20MCG/ML (20MCG/ML) ^[RLD]

Has a generic version of Ventavis been approved?

No. There is currently no therapeutically equivalent version of Ventavis available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ventavis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ventavis.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 29, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Ventavis Consumer Information (Drugs.com)
• Ventavis Consumer Information (Wolters Kluwer)
• Ventavis Consumer Information (Cerner Multum)
• Ventavis Advanced Consumer Information (Micromedex)
• Ventavis AHFS DI Monographs (ASHP)
• Iloprost Consumer Information (Wolters Kluwer)
• Iloprost Consumer Information (Cerner Multum)
• Iloprost Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Iloprost AHFS DI Monographs (ASHP)